Drug Shortage Report for LUPIN-CEPHALEXIN
| Report ID | 165025 |
| Drug Identification Number | 02469189 |
| Brand name | LUPIN-CEPHALEXIN |
| Common or Proper name | LUPIN-CEPHALEXIN |
| Company Name | LUPIN PHARMA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | CEPHALEXIN |
| Strength(s) | 250MG |
| Dosage form(s) | POWDER FOR SUSPENSION |
| Route of administration | ORAL ORAL |
| Packaging size | 100 and 150 ML |
| ATC code | J01DB |
| ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2022-07-20 |
| Estimated end date | 2022-10-31 |
| Actual end date | 2022-10-12 |
| Shortage status | Resolved |
| Updated date | 2022-10-12 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 550-1111 RUE ST-CHARLES OUEST LONGUEUIL, QUEBEC CANADA J4K 5G4 |
| Company contact information | lupin@lsu3pl.ca (Customer service / Service à la clientèle) |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2022-10-12 | French | Compare |
| v6 | 2022-10-12 | English | Compare |
| v5 | 2022-09-08 | French | Compare |
| v4 | 2022-09-08 | English | Compare |
| v3 | 2022-07-21 | English | Compare |
| v2 | 2022-07-20 | French | Compare |
| v1 | 2022-07-20 | English | Compare |
Showing 1 to 7 of 7